OTC Markets EXMKT - Delayed Quote USD

Global Cord Blood Corporation (CORBF)

Compare
1.2500 0.0000 (0.00%)
At close: October 15 at 4:00 PM EDT
Loading Chart for CORBF
DELL
  • Previous Close 1.7500
  • Open 1.7500
  • Bid --
  • Ask --
  • Day's Range 1.7500 - 1.7500
  • 52 Week Range 0.8500 - 2.0000
  • Volume 1,125
  • Avg. Volume 2,445
  • Market Cap (intraday) 200.872M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) 3.05
  • EPS (TTM) 0.4100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 31, 2018
  • 1y Target Est --

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

www.globalcordbloodcorp.com

1,202

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CORBF

View More

Performance Overview: CORBF

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CORBF
0.00%
S&P 500
22.49%

1-Year Return

CORBF
0.00%
S&P 500
35.00%

3-Year Return

CORBF
71.85%
S&P 500
30.66%

5-Year Return

CORBF
74.17%
S&P 500
95.03%

Compare To: CORBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CORBF

View More

Valuation Measures

Annual
As of 7/12/2024
  • Market Cap

    200.87M

  • Enterprise Value

    -721.78M

  • Trailing P/E

    3.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.22

  • Price/Book (mrq)

    0.24

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.30%

  • Return on Assets (ttm)

    4.63%

  • Return on Equity (ttm)

    10.99%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    501.06M

  • Diluted EPS (ttm)

    0.4100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.66B

  • Total Debt/Equity (mrq)

    0.00%

  • Levered Free Cash Flow (ttm)

    378.58M

Research Analysis: CORBF

View More

Company Insights: CORBF

Research Reports: CORBF

View More

People Also Watch